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RESUMO.- [Efeito do acetato de medroxi-progesterona
sobre o crescimento filicular e expressão endometrial
de ciclooxigenase-2 (COX-2) durante o ciclo estral de
bovinos.] Este estudo teve como objetivo avaliar o efeito
do acetato de medroxi-progesterona (MAP) com ou sem
benzoato de estradiol (BE) sobre o crescimento folicular
durante o ciclo estral bovino. No primeiro experimento,
vacas da raça Hereford foram sincronizadas com um aná-
logo sintético de PGF2á e tratadas com duas doses dife-
rentes de MAP (250 ou 500mg), com ou sem EB, durante
7 dias, iniciando-se no oitavo dia do ciclo estral. Obser-
vou-se uma inibição do crescimento folicular (P<0,05) em
todas as vacas, exceto no grupo controle e no grupo que
recebeu 250mg de MAP sem BE. Os 75% dos animais
não exibiu estro no momento da remoção do MAP, mas
sim nos dias 21 e 22 do ciclo, demonstrando que os trata-
mentos não induziram cio. Para se determinar se o trata-
mento com BE alterou a sensibilidade endometrial à
ocitocina e, assim, a cascata luteolítica, vacas multíparas
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The objective of this study was to evaluate the effect of medroxy-progesterone acetate
(MAP) with or without estradiol benzoate (EB) on follicular growth during the estrous cycle
in cattle. In the first experiment, Hereford cows were synchronized with a synthetic analogue
of PGF
2
 alpha and were treated with two different doses of MAP (250 or 500 mg) with or
without EB for 7 days starting on day 8 of the estrous cycle. Follicular growth was inhibited
(P<0.05) in all cows except controls and those receiving 250mg MAP without EB. Seventy-
five percent of the animals (15/20) showed estrus on days 21 and 22 of the cycle rather
than at MAP withdrawal, demonstrating that these treatments did not induce estrus. To
determine whether the EB treatment altered endometrial sensitivity to oxytocin and thus
the luteolytic cascade, multiparous pre-synchronized cows received 5 mg of EB followed
6 hours later with 50 IU of oxytocin (OT; n=9). Eight hours after EB injection, endometrial
fragments were collected from the cows on days 4, 13 and 17 of the estrous cycle and
COX-2 gene expression was measured by PCR. EB increased COX-2 mRNA levels only
on day 17 of the estrous cycle (P<0.05). In conclusion, MAP alone or associated with EB
is able to suppress bovine follicular growth. However, EB in the presence of MAP is not
efficient to induce luteolysis in cows when injected on day 8 of the estrous cycle.
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pré-sincronizadas receberam 5mg de BE, seguidos, após
6 horas, de 50 UI de ocitocina (OT; n=9). Oito horas após
a administração de BE, colheram-se fragmentos endome-
triais das vacas, nos dias 4, 13 e 17 do ciclo estral,
mensurando-se a expressão gênica de COX-2 através de
PCR. O BE aumentou os níveis de RNAm de COX-2 ape-
nas no dia 17 do ciclo estral (P<0,05). Em conclusão, o
MAP isolado ou associado a BE é capaz de suprimir o
crescimento folicular bovino. Entretanto, o BE, na presen-
ça de MAP é ineficaz na indução da luteólise bovina, quan-
do injetado no oitavo dia do ciclo estral.
TERMOS DE INDEXAÇÃO: Crescimento folicular, benzoato
de estradiol, acetato de medroxi-progesterona, bovinos de corte,
luteólise.
INTRODUCTION
Although the use of progesterone to inhibit ovulation and
synchronize estrus has been widely employed in cattle
(Martìnez et al.  2007, Small et al.  2009), the use of
synthetic progestins in cattle is less well known. Medroxy-
progesterone acetate (MAP) is cheaper than natural
progesterone and is a potentially good option for extensive
farming practices in Brazil. MAP has been used to induce
estrus in post-partum beef cattle (Medeiros Bastos et
al.  2004, Terra et al.  2008), and its use in synchroniza-
tion of cyclic cattle within an Ovsynch protocol has been
reported (Cavestany et al.  2003, Terra et al.  2008).
Depending on stage of cycle, the dominant follicle subject
to exposure to MAP may be the follicle that ovulates at
MAP withdrawal (Burke et al. 1996), therefore the impact
of MAP synchronization protocols on follicle dynamics
requires elucidation.
High concentrations of progesterone have been shown
to limit follicular growth (Adams et al.  1992, Burke et al.
1996) and induce atresia of persistent follicles (Savio et
al.  1993, Stock & Fortune  1993, Anderson & Day  1994).
Additionally, exogenous estradiol induces atresia of the
dominant follicle (Bo et al.  1995, Kinder et al.  1996) and
induces luteolysis (Thatcher et al.  1986), leading to the
emergence of a new follicle wave 3 to 4 days after the
initiation of treatment (Kinder et al.  1996). Although the
feedback mechanisms of estradiol and progesterone on
LH secretion are different (Price & Webb  1988), when
administered in combination, estradiol greatly enhances
the ability of progesterone to suppress the LH surge in
ovariectomized ewes and cows (Stumpf et al.  1993, Cupp
et al.  1995). The effect of exogenous estradiol on MAP
synchronization protocols is not known.
The aim of this experiment was to determine the
influence of two different concentrations of MAP, with or
without exogenous estradiol, on follicular growth and
induction of estrus under typical extensive farming
conditions in Brazil. As the expression of estrus is
dependent on the ability of treatments to induce luteolysis,
we also measured the effect of exogenous estradiol on
uterine sensitivity to oxytocin.
MATERIALS AND METHODS
Experiment 1
Twenty Hereford cows at a body condition score of 4 (1=lean;
5=overweight) were housed at the Embrapa Sul experimental
farm in Bagé, Rio Grande do Sul. The animals were pre-
synchronized by an injection of 500μg of cloprostenol (Sincrocio,
Ourofino, Brazil). Twenty-four hours later, the animals were
observed for detection of estrus.
After the detection of estrus, the animals were randomly
allocated to one of 5 groups as follows: control group (n=3);
group MAP250BE (n=4) received an intra-vaginal device (IVD)
with 250mg MAP (Purifarma, SP, Brazil) and an intramuscular
(IM) injection of 5 mg of estradiol benzoate (EB) (Purifarma, SP,
Brazil) diluted in vegetable oil; group MAP250 (n=5) received an
IVD containing 250mg MAP; group MAP500BE (n=4) received
an IVD containing 500mg MAP and an IM injection of 5mg of EB
diluted in vegetable oil; and group MAP500 (n=4) received an
IVD containing 500mg MAP. The treatments were given on day
8 of the estrous cycle. The IVDs were removed on the day 14 of
estrous cycle, and estrus detection started thereafter.
All groups were evaluated by ultrasound through a Pie
Medical model 480 (Pie Medical, The Netherlands) equipped
with a transrectal linear 5 MHz real time transducer, and
connected to a VHS recorder set. During each evaluation, a
complete scanning of the ovaries was performed, and the
diameters of the largest and second largest follicles were
measured. The evaluations took place on the first day of the
treatment and once every 2 days for 14 days.
Experiment 2
Animals and sample collection. Eighteen Red Angus and
Nelore-cross cows, between three and four years old, were
raised extensively in a private farm in Sao Gabriel, Rio Grande
do Sul, Brazil. Every animal was pre-synchronized with 500μg
cloprostenol. The animals were separated in two groups. The
treated animals (n=9) received 5mg EB and followed six hours
later with 50 IU oxytocin (OT) (Placentina, Usinas Chimicas
Brasileiras S.A., Brazil). The control group (n=9) received 50 IU
OT only. The treatments were applied at three different moments
of estrous cycle, day 4, 13 or 17; thus there were three animals
per group/time (2 Angus and 1 Nelore). The OT challenge was
used because estradiol upregulates OT receptor mediated
expression of COX-2 (Burke et al. 1996). Two hours after OT
injection, fragments of endometrium were collected under
sedation and caudal epidural anesthesia. An incision was
performed on the dorsal region of the vagina, vertically and
over the first portion of the cervix. The tissues were stored in
RNA Later ® (Qiagen) and frozen in liquid nitrogen. All animal
procedures were approved by the Bioethics Committee of the
College of Veterinary Medicine, Federal University of Santa
Maria.
Nucleic acid extraction & semi-quantitative RT-PCR.
Gene expression was assayed by RT-PCR. Total RNA (1 mg)
was first treated with 1 U DNase (Promega, Madison, WI) at
37°C for 30 min to digest any contaminating DNA, followed by
adding 1ml EDTA stop buffer at 65°C for 10 min. The RNA was
reverse transcribed in the presence of 1mM oligo(dT) primer
and 4 U Omniscript RTase (Qiagen, USA), 0.25mM dideoxy-
nucleotide triphosphate (dNTP) mix, and 19.33 U RNase
Inhibitor (Amersham Biosciences, USA) in a volume of 20ml at
37°C for 1 h. The reaction was terminated by incubation at
93°C for 5min.
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Bovine-specific primers for COX-2 (Pfaffl et al.  2003) and histone
H2a (Hayashi et al.  2003) were used. PCR of fixed amounts of RNA
indicated that H2a amplicon abundance was stable across
treatments, whereas amounts of another housekeeping gene,
glyceraldehyde-3-phosphate dehydrogenase, were found to vary.
An aliquot (1ml) of the cDNA template was amplified by PCR using
0.25ml (2.5 U) Taq Polymerase (Amersham Pharmacia Biotech
Inc., USA) in a 20-ml PCR buffer (Amersham Pharmacia Biotech
Inc.) containing 0.1 mM dNTP mix, and 0.2 mM specific primers.
After an initial denaturation step for 3min at 94°C, target cDNA was
amplified with a denaturation step at 94°C for 60 sec, annealing for
45sec at 60°C (COX-2) or at 58°C for 30sec (H2a), and elongation
at 72°C for 1min. All reactions were terminated with a final elongation
at 72°C for 5min. Reactions was performed for 30 cycles for COX-2
and for H2a, 29 cycles.
The PCR products were separated on 2% agarose gels
containing 0.001% ethidium bromide, and visualized under UV
light. Quantification of band intensity was performed with Image
J (NIH, USA). The use of animals in these experiments was in
accordance with the Guide to the Care and Use of Experimen-
tal Animals (Canadian Council on Animal Care, 315-350 Albert
Street, Ottawa, Ontario, K1R 1B1) and was approved by the
animal care committee of the authors’ institution.
Statistical analysis
The effect of treatments on diameter of the largest follicle
was tested by ANOVA. Dominance was determined by
measuring the diameters of the two largest follicles by
ultrasound. ANOVA for repeated measures was used to com-
pare results in the same group, where the class was the day
and the factor of repetition was the cow.
Data that did not follow a normal distribution pattern (Shapiro-
Wilk’s test) were transformed to logarithms. Homogeneity of
variance was tested with O’Brien and Brown-Forsythe’s tests.
All analytical procedures were performed with JMP software
(SAS Institute, USA) with treatment group as main effect and
cow replicate as a random variable in F-test. For gene
expression data, housekeeping gene abundance was included
as a covariate in the main effects model. Differences between
means were tested with the Tukey-Kramer’s HSD test. Data are
presented as means ± SEM.
RESULTS
Experiment 1. Wave dynamics of the dominant and subordinate
follicles in each treatment group are shown in Figure 1. The growth
of the dominant follicle was suppressed in animals receiving 500mg
Fig.1. Diameters of the dominant (DF) and
largest subordinate (SF) follicles in
cattle receiving intravaginal devices
containing 250 or 500mg MAP, with or
without EB. Devices were inserted on
day 8 and removed on day 14. Follicle
diameters were recorded by transrectal
ultrasonography. The number of animals
in each group is given in each panel.
Data are presented as means ± SEM.
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MAP with or without EB, and in animals receiving 250mg MAP
with EB (P<0.05). The maximum diameter of the dominant follicle
in the 250mg MAP group without EB was not different from the
controls. A difference in diameter between the two largest follicles
was detected only in Control and MAP250 groups (P<0.05) (Fig.2),
indicating the presence of follicular waves in those two groups.
Estrus was not detected after withdrawal of IVDs as expected, but
occurred on days 21 and 22 of the estrous cycle in 75% of the
animals; the remainder had not shown estrus by day 22.
Experiment 2. EB significantly (P<0.05) increased
endometrial COX-2 mRNA abundance on day 17 of the
cycle, but had no effect on days 4 and 13 of the cycle  (Fig.3)
irrespective of the treatment with exogenous estradiol.
DISCUSSION
The use of synthetic progestins in IVD is not widespread in
cattle. The objective of this study was to determine the
effects of MAP on follicle dynamics, and whether exogenous
estradiol was capable of inducing luteolysis and a new follicle
wave. This information has implications for implanting simple
and cost effective estrus synchronization protocols suitable
for extensive farming practices in Brazil.
Altering progesterone concentrations during the cycle has
impact on gonadotropin secretion. High levels inhibit LH pul-
se secretion whereas lower sub-luteal levels result in raised
LH secretion (Stock & Fortune 1993). Extended periods under
sub-luteal concentrations of progesterone, such as CIDR or
MAP synchronization protocols, prolong the period of follicular
dominance, maintain high levels of estradiol, and reduce
oocyte viability and fertility (Stock & Fortune 1993, Mihm et
al. 1994). In Experiment 1, we demonstrated that MAP at a
dose of 250 mg alone is incapable of blocking follicular growth,
whereas at the higher dose of MAP, the dominant follicle
failed to reach its normal size. These data agree with earlier
studies, in which 300mg MAP failed to alter the growth of
the dominant follicle (Cavestany et al. 2003), or where rising
concentrations of the synthetic progestin norgestomet
inhibited growth of the dominant follicle (Sanchez et al.  1995).
It is known that estradiol enhances the inhibitory influence
of progestagens on LH release (Price & Webb 1988). In
agreement with this, the addition of EB to the 250mg MAP
dose inhibited follicle growth compared to MAP alone.
Although LH pulse secretion was not measured, it is likely
that EB enhanced the inhibitory effect of progesterone on
LH pulse frequency. Despite the inhibition of follicle growth
during MAP+EB treatment, data suggest that follicle growth
following IVD removal is not affected by pretreatment with
MAP (Borges et al. 2008).
In the present experiment, estrus was not synchronized
but occurred at the normal time, on day 21 and 22 of the
cycle. This was because the animals were pre-synchronized
with PG and all treatments started on day 8 of the cycle. All
animals thus had a functional corpus luteum during and after
IVD placement. This designed allowed the study of follicle
dynamics under controlled conditions, and allowed us to
determine whether EB would cause luteolysis in this model.
As the follicle data and lack of estrus synchronization shows,
EB did not induce luteolysis when given with MAP on day 8
of the cycle.
Estradiol is believed to induce luteolysis by increasing
endometrial OT receptor expression, and thus OT induction
of COX-2 and PG synthesis (Thatcher et al.  1986, Kombe
et al. 2003). To determine whether the inability of EB treatment
to induce estrus in this study was related to responsiveness
to OT, COX-2 mRNA levels were assessed following OT
challenge. EB did not increase COX-2 expression until day
17 of the cycle, consistent with the lack of luteolysis and
synchronization of estrus observed in Experiment 1. This is
later than the mid-cycle response reported earlier (Thatcher
et al. 1986), and may be influenced by dose of EB or OT
used in the present study.
In conclusion higher doses of MAP alone or lower doses
of MAP in conjunction with EB are able to suppress growth
of the dominant follicle in cattle. Although the injection of
Fig.2. Effect of treatments on the difference in diameter between
the dominant and subordinate follicle during the treatment
estrous cycle. Animals received intravaginal devices
containing 250 or 500mg MAP, with or wit hout EB. Devices
were inserted on day 8 and removed on day 14. Data are
presented as means.
Fig.3. Effect of estradiol benzoate (EB) treatment on oxytocin-
induced COX-2 mRNA abundance in the endometrium on
days 4, 13 and 17 of the cycle. Animals were injected with
EB or saline 6 h before injection of oxytocin. Endometrial
samples were collected 2 h later. COX-2 mRNA was
measured by RT-PCR. Data are presented as means ± SEM
and asterisk indicates a significant effect of EB (P<0.05).
Pesq. Vet. Bras. 30(7):581-585, julho 2010
Effect of medroxy-progesterone acetate on follicular growth and endometrial cycloxygenase-2 (COX-2) 585
EB at start of MAP treatment was potent in suppressing
follicle growth, it did not induce luteolysis at midcycle.
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